ADPT

16.21

1.00% 0.16

Dopo l'orario di chiusura: 16.21

Adaptive Biotechnologies Corp (ADPT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ADPT Giù? Forum Previsione

Precedente Chiudi:

$16.05

Aprire:

$16.18

Volume 24 ore:

1.08M

Relative Volume:

0.47

Capitalizzazione di mercato:

$2.49B

Reddito:

$205.22M

Utile/perdita netta:

$-121.24M

Rapporto P/E:

-19.91

EPS:

-0.8141

Flusso di cassa netto:

$-82.81M

1 W Prestazione:

+2.14%

1M Prestazione:

-12.61%

6M Prestazione:

+27.94%

1 anno Prestazione:

+92.52%

Intervallo 1D:

$15.85

$16.50

Intervallo di 1 settimana:

$14.75

$16.50

Portata 52W:

$6.255

$20.76

Adaptive Biotechnologies Corp Stock (ADPT) Company Profile

Nome

Adaptive Biotechnologies Corp

Settore

Healthcare (1108)

Industria

Biotechnology (621)

Telefono

206-659-0067

Indirizzo

1165 EASTLAKE AVE E, SEATTLE, WA

Dipendente

619

Cinguettio

@adaptivebiotech

Prossima data di guadagno

2025-02-11

Ultimi documenti SEC

ADPT's Discussions on Twitter

Compare ADPT vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ADPT Adaptive Biotechnologies Corp	16.21	2.47B	205.22M	-121.24M	-82.81M	-0.8141
VRTX Vertex Pharmaceuticals Inc	483.05	123.82B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	784.28	81.64B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	816.95	52.00B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	327.36	44.14B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	352.23	40.83B	4.98B	69.60M	525.67M	0.5198

Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-02	Ripresa	Morgan Stanley	Equal-Weight
2025-09-30	Iniziato	Guggenheim	Buy
2025-06-18	Iniziato	Craig Hallum	Buy
2025-03-21	Aggiornamento	Goldman	Neutral → Buy
2023-07-05	Ripresa	JP Morgan	Overweight
2023-01-05	Iniziato	Scotiabank	Sector Outperform
2022-12-21	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-08-25	Iniziato	Credit Suisse	Underperform
2022-06-03	Iniziato	Piper Sandler	Neutral
2022-02-16	Reiterato	BTIG Research	Buy
2022-02-16	Reiterato	BofA Securities	Buy
2022-02-16	Reiterato	Goldman	Neutral
2022-02-16	Reiterato	JP Morgan	Overweight
2021-10-15	Ripresa	Cowen	Outperform
2021-03-03	Downgrade	Goldman	Buy → Neutral
2020-10-08	Ripresa	BTIG Research	Buy
2020-09-09	Iniziato	Morgan Stanley	Equal-Weight
2020-06-03	Iniziato	Goldman	Buy
2019-07-23	Iniziato	BTIG Research	Buy
2019-07-22	Iniziato	BofA/Merrill	Buy
2019-07-22	Iniziato	Cowen	Outperform
2019-07-22	Iniziato	Goldman	Neutral
2019-07-22	Iniziato	Guggenheim	Buy
2019-07-22	Iniziato	William Blair	Outperform

Mostra tutto

Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie

Feb 21, 2026

TD Cowen is Bullish on Adaptive Biotechnologies Corporation (ADPT) - Finviz

Feb 21, 2026

Feb 13, 2026

Principal Financial Group Inc. Sells 303,285 Shares of Adaptive Biotechnologies Corporation $ADPT - MarketBeat

Feb 13, 2026

Feb 11, 2026

Buy Signal: What is the earnings history of EUDAW2025 Technical Overview & Free Community Consensus Stock Picks - baoquankhu1.vn

Feb 11, 2026

Allianz Asset Management GmbH Raises Stock Holdings in Adaptive Biotechnologies Corporation $ADPT - MarketBeat

Feb 11, 2026

Feb 08, 2026

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year - Yahoo Finance

Feb 08, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Feb 08, 2026

Feb 06, 2026

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) CFO Sells 2,145 Shares of Stock - MarketBeat

Feb 06, 2026

ADPT: BTIG Raises Price Target Following Analyst Update | ADPT S - GuruFocus

Feb 06, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $21.00 - MarketBeat

Feb 06, 2026

ADPT: JP Morgan Raises Price Target and Maintains Overweight Rat - GuruFocus

Feb 06, 2026

Adaptive Biotechnologies (ADPT) stock swings after earnings as MRD guidance, insider sale draw scrutiny - TechStock²

Feb 06, 2026

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 06, 2026

Adeptus Biotechnologies stock price target raised to $22 by BTIG on strong MRD growth By Investing.com - Investing.com Nigeria

Feb 06, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat

Feb 06, 2026

Adeptus Biotechnologies stock price target raised to $22 by BTIG on strong MRD growth - Investing.com UK

Feb 06, 2026

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times

Feb 06, 2026